Home » Topics » Disease categories and therapies » Neurology/psychiatric

Neurology/psychiatric
RSS

BMS to comarket antiemetic azasetron in Japan

June 27, 1997

NDA for entacapone scheduled for submission this month

June 27, 1997

Preclinical profile of MDL-27192

June 27, 1997

SKB discovers first selective human 5-HT1B receptor ligand

June 27, 1997

Novel anxiolytic and antidepressant buspirone analogue characterized

June 27, 1997

MS&D reports another series of potent and selective 5-HT1D agonists

June 27, 1997

NMDA antagonists improve memory deficits after brain injury in the rat

June 26, 1997

Univ. of Tokyo scientists isolate potent and selective papain inhibitor

June 26, 1997

Efficacy of SB-206284A in animal models of cerebral ischemia

June 26, 1997

MS&D prepares potent and selective 5-HT1D agonists

June 26, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 31, 2026.
New schizophrenia targets challenge trial design
BioWorld
The search for better schizophrenia therapies is moving beyond dopamine toward a growing number of experimental targets. According to researchers, the repeated...
AIDS 2026: New targets for metabolic dysfunction despite ART
BioWorld
Although antiretroviral therapy (ART) can suppress HIV to undetectable levels, a growing body of evidence suggests that the virus leaves a lasting biological...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 28, 2026
Jingxin discloses new muscarinic and sigma receptor agonists
BioWorld Science
Shanghai Jingxin Biopharmaceutical Co. Ltd. and Zhejiang Jingxin Pharmaceutical Co. Ltd. have synthesized new muscarinic acetylcholine receptor and sigma receptor...